News
SES AI Corporation ("SES AI") (NYSE: SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today announced it will release its 2025 ...
1d
VELO on MSNColnago Y1Rs vs Cervélo S5: Battle for Aero Supremacy
Two of the top aero bikes in the Tour de France peloton, the Colnago Y1Rs and the Cervélo S5, go head to head in this test.
SES announced Thursday that it has completed its $3.1 billion acquisition of McLean-based satellite services provider Intelsat.
SES finalized its $3.1 billion purchase of Intelsat, positioning itself as a stronger multi-orbit competitor with a fleet of ...
SES, a leading space solutions company, today announced the completion of its highly value accretive acquisition of Intelsat, creating a strengthened global satellite operator with an expanded fleet ...
Nicotine vaping continues to outperform FDA-approved smoking cessation therapies in well-designed studies, including a new clinical trial conducted in Australia. This growing body of evidence badly ...
FCC Chairman Brendan Carr announced that the agency approved three separate transactions this week that involve wireless, ...
Satellite operators are squeezed by LEO competitors and more fiber on the ground. On that basis, the FCC greenlit the ...
FCC expects SES' proposed purchase of Intelsat to establish a "more vigorous multi-orbit competitor in the satellite ...
July 11th saw the clearest indication that the long wait for SES to receive its permissions to acquire rival Intelsat is ...
SES AUA 2025 phase 1 trial of mevrometostat (PF-06821497), mevrometostat with enzalutamide plus ADT, abiraterone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results